Three studies presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting discussed whether ...

Pre-diabetes now affects as many as one-third of children ages 12-17. As a physician this is why Ozempic should still not be ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Fitness experts say using weight-loss drugs is just one piece of the puzzle for many attempting to live healthier ...

Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.